“With MiBioLab we found a trustful partner for our R&D activities with profound expertise in strain characterization and bioprocess optimization."

 Alain Sourabié (PhD), Director Science Technology & Innovation Lesaffre - BU Procelys


“For Enzymaster it is important to work with a reliable partner who has know-how in the field of bioprocess development and optimization and who can guarantee not only a high throughput of experiments, but also the scalability of experimental results to industrial standards. We have found this with MiBioLab and look forward to continuing this very successful cooperation.“

Dr. Thomas Daußmann, Executive Vice President International Business Enzymaster (Ningbo) Bio-Engineering Co., Ltd., Managing Director Enzymaster Deutschland GmbH

“We maintain a longstanding and very fruitful partnership with the people involved in MiBioLab. The bi-directional transfer of knowledge between m2p-labs and the expert users in MiBioLab is a very valuable source of first-hand constructive criticism for m2p-labs. We are very pleased about the excellent cooperation with MiBioLab and plan to continue this strategically important partnership in the field of technologies without any restrictions.“

Dr. Christoph Petry, CEO m2p-labs GmbH

“Ohly GmbH is part of the ABF ingredients family and represents a leading supplier of yeast-based fermentation nutrients. The ongoing cooperation with MiBioLab relies on their in-house automated microbioreactor technology platform to provide detailed application studies on characterizing the impact of our product on the specific production processes of our customers. This improved knowledge about our product application is an asset, supporting us in recommending the application specific optimal Ohly product to our customers to optimize their bioprocesses towards higher performance and process economics.”

Katelijne Bekers, Business Development Manager Bionutrients Ohly GmbH

“We have already placed two orders with MiBioLab. The longstanding expertise in the field of bioprocesses in combination with state of the art technologies have proved to be a substantial benefit for our research and business.”

Dr. Georg Schaumann, CEO SenseUp GmbH